NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Vyndaqel Capsules Special Investigation (ATTR-CM)

CompletedN/A

Sponsor: Pfizer

Conditions: Transthyretin (TTR) Amyloid Cardiomyopathy

Interventions: Treatment for TTR amyloidosis, Treatment for TTR amyloidosis

Countries: Japan

Secondary Data Collection : To confirm the safety and effectiveness profiles under the actual medical practice of Vyndaqel in Japan. This study is conducted in accordance with the protocol even when Vynmac is used, and information the use of Vynmac during the observation period is also collected.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Patients administered Vyndaqel for the treatment of ATTR-CM

Exclusion Criteria:

* N/A

Locations (1)

Tokyo, Japan